News|Articles|April 9, 2024
Best Practices for Tech Transfer to Avoid Manufacturing Pitfalls
Author(s)Scorpius BioManufacturing
Ensure the success of clinical biomanufacturing programs by focusing on key tech transfer practices from the sponsor, commercial, scientific, and program management stakeholders.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals
2
Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina
3
Agenus Closes $141 Million Immunotherapy Collaboration with Zydus Lifesciences
4
Why Biotech’s Clinical Maturity Is Driving New Partnerships and Capacity Plays
5